rs35379457

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_017433.5(MYO3A):​c.1104C>T​(p.Tyr368Tyr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.52 in 1,585,094 control chromosomes in the GnomAD database, including 220,702 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.47 ( 17865 hom., cov: 33)
Exomes 𝑓: 0.53 ( 202837 hom. )

Consequence

MYO3A
NM_017433.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.123

Publications

14 publications found
Variant links:
Genes affected
MYO3A (HGNC:7601): (myosin IIIA) The protein encoded by this gene belongs to the myosin superfamily. Myosins are actin-dependent motor proteins and are categorized into conventional myosins (class II) and unconventional myosins (classes I and III through XV) based on their variable C-terminal cargo-binding domains. Class III myosins, such as this one, have a kinase domain N-terminal to the conserved N-terminal motor domains and are expressed in photoreceptors. The protein encoded by this gene plays an important role in hearing in humans. Three different recessive, loss of function mutations in the encoded protein have been shown to cause nonsyndromic progressive hearing loss. Expression of this gene is highly restricted, with the strongest expression in retina and cochlea. [provided by RefSeq, Jul 2008]
MYO3A Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 30
    Inheritance: AR, SD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hearing loss, autosomal dominant 90
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.38).
BP6
Variant 10-26068818-C-T is Benign according to our data. Variant chr10-26068818-C-T is described in ClinVar as Benign. ClinVar VariationId is 45796.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.123 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.55 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYO3ANM_017433.5 linkc.1104C>T p.Tyr368Tyr synonymous_variant Exon 12 of 35 ENST00000642920.2 NP_059129.3 Q8NEV4-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYO3AENST00000642920.2 linkc.1104C>T p.Tyr368Tyr synonymous_variant Exon 12 of 35 NM_017433.5 ENSP00000495965.1 Q8NEV4-1
MYO3AENST00000543632.5 linkc.1104C>T p.Tyr368Tyr synonymous_variant Exon 11 of 17 1 ENSP00000445909.1 F5H0U9
MYO3AENST00000642197.1 linkn.1308C>T non_coding_transcript_exon_variant Exon 12 of 27
MYO3AENST00000647478.1 linkn.1104C>T non_coding_transcript_exon_variant Exon 11 of 30 ENSP00000493932.1 A0A2R8Y4D5

Frequencies

GnomAD3 genomes
AF:
0.475
AC:
71993
AN:
151654
Hom.:
17861
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.359
Gnomad AMI
AF:
0.433
Gnomad AMR
AF:
0.410
Gnomad ASJ
AF:
0.533
Gnomad EAS
AF:
0.271
Gnomad SAS
AF:
0.493
Gnomad FIN
AF:
0.578
Gnomad MID
AF:
0.602
Gnomad NFE
AF:
0.555
Gnomad OTH
AF:
0.476
GnomAD2 exomes
AF:
0.478
AC:
119851
AN:
250570
AF XY:
0.490
show subpopulations
Gnomad AFR exome
AF:
0.353
Gnomad AMR exome
AF:
0.318
Gnomad ASJ exome
AF:
0.528
Gnomad EAS exome
AF:
0.271
Gnomad FIN exome
AF:
0.579
Gnomad NFE exome
AF:
0.553
Gnomad OTH exome
AF:
0.504
GnomAD4 exome
AF:
0.525
AC:
752551
AN:
1433324
Hom.:
202837
Cov.:
33
AF XY:
0.526
AC XY:
375451
AN XY:
714322
show subpopulations
African (AFR)
AF:
0.356
AC:
11759
AN:
33034
American (AMR)
AF:
0.330
AC:
14704
AN:
44576
Ashkenazi Jewish (ASJ)
AF:
0.520
AC:
13445
AN:
25842
East Asian (EAS)
AF:
0.262
AC:
10334
AN:
39448
South Asian (SAS)
AF:
0.482
AC:
41232
AN:
85620
European-Finnish (FIN)
AF:
0.575
AC:
30508
AN:
53058
Middle Eastern (MID)
AF:
0.555
AC:
3168
AN:
5704
European-Non Finnish (NFE)
AF:
0.549
AC:
596928
AN:
1086626
Other (OTH)
AF:
0.513
AC:
30473
AN:
59416
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.424
Heterozygous variant carriers
0
16509
33019
49528
66038
82547
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16336
32672
49008
65344
81680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.474
AC:
72009
AN:
151770
Hom.:
17865
Cov.:
33
AF XY:
0.474
AC XY:
35133
AN XY:
74148
show subpopulations
African (AFR)
AF:
0.359
AC:
14888
AN:
41436
American (AMR)
AF:
0.409
AC:
6235
AN:
15252
Ashkenazi Jewish (ASJ)
AF:
0.533
AC:
1843
AN:
3456
East Asian (EAS)
AF:
0.271
AC:
1402
AN:
5170
South Asian (SAS)
AF:
0.492
AC:
2375
AN:
4828
European-Finnish (FIN)
AF:
0.578
AC:
6084
AN:
10524
Middle Eastern (MID)
AF:
0.586
AC:
171
AN:
292
European-Non Finnish (NFE)
AF:
0.555
AC:
37613
AN:
67794
Other (OTH)
AF:
0.476
AC:
1005
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1874
3748
5621
7495
9369
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
660
1320
1980
2640
3300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.521
Hom.:
11927
Bravo
AF:
0.451
Asia WGS
AF:
0.397
AC:
1380
AN:
3476
EpiCase
AF:
0.556
EpiControl
AF:
0.560

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
May 09, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

May 07, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Tyr368Tyr in Exon 12 of MYO3A: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue, is not located withi n the splice consensus sequence, and has been identified in 49.1% (3446/7020) of European American chromosomes from a broad population by the NHLBI Exome Sequen cing Project (http://evs.gs.washington.edu/EVS; dbSNP rs35379457). -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal recessive nonsyndromic hearing loss 30 Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.38
CADD
Benign
2.4
DANN
Benign
0.44
PhyloP100
-0.12
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35379457; hg19: chr10-26357747; COSMIC: COSV56322248; API